Form 4: Ameren Executive Sells Shares in Pre-Planned Transaction
Insider Transaction Report
Ameren SVP & CSO of Subsidiary, Gwendolyn G. Mizell, sold 3,548 shares of common stock for $110.9 per share in a pre-planned transaction.
Summary
- Gwendolyn G. Mizell, SVP & CSO of a subsidiary of Ameren Corp (AEE), reported a transaction involving the company's common stock.
- On February 17, 2026, Mizell disposed of 3,548 shares of Ameren Common Stock, $.01 Par Value, at a price of $110.9 per share.
- The transaction was executed pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
- Following the reported transaction, Mizell directly beneficially owns 7,267 shares of Ameren Common Stock.
- Additionally, Mizell indirectly holds an estimated 2,423 share equivalents in the unitized stock fund within the Ameren Corporation Savings Investment Plan as of January 31, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction, pre-planned under Rule 10b5-1, which mitigates any negative sentiment typically associated with insider selling.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common and often reflect personal financial planning rather than a negative outlook on the company's prospects. Such pre-planned transactions help insiders avoid accusations of trading on material non-public information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 02/17/2026 | Indicates adherence to best practices for insider trading, reducing the perception of opportunistic selling and enhancing transparency. |
Stakeholder Impact
- Shareholders: May observe the sale as a routine insider transaction, especially given the 10b5-1 plan, which typically does not signal a change in company fundamentals. The remaining beneficial ownership indicates continued alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 01/31/2026 | Estimated date for share equivalents held in 401(K) plan. |
| 02/17/2026 | Date of common stock disposition by Gwendolyn G. Mizell. |
| 02/19/2026 | Date the Form 4 was signed and filed. |
Recommendation
holdA single, pre-planned insider sale, as disclosed in this Form 4, is generally not considered a significant indicator for a change in investment recommendation. The transaction appears to be part of routine personal financial management rather than a reflection of the company's fundamental performance or outlook. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions while monitoring broader company and industry developments.
Keywords
Ameren, AEE, Insider Trading, Form 4, Stock Sale, Executive Compensation, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.